We therefore elected to utilise aged (9–11 months) mammary tissue for further experiments, because this age in mice corresponds to perimenopausal middle age in humans25, at which time the incidence of breast cancer in female BRCA2 mutation carriers increases. This evidence concerns the gene BRCA2 and breast cancer.